Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5′UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's Disease

Substance Use and Misuse

Volumn 45, Issue 11, 2010, Pages 1809-1826

  Chiocco, Matthew J ^a   Zhu, Xuguang ^a   Walther, Donna ^a   Pletnikova, Olga ^b   Troncoso, Juan C ^b   Uhl, George R ^a   Liu, Qing Rong ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative splicing; Gene regulation; Phosphatase; SNP association

Indexed keywords

CALCINEURIN; ISOPROTEIN; PPP3CA PROTEIN, HUMAN; RNA;

5' UNTRANSLATED REGION; ADDICTION; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; BRAIN; GENE FREQUENCY; GENETICS; HUMAN; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRINUCLEOTIDE REPEAT;

5' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; BEHAVIOR, ADDICTIVE; BRAIN; CALCINEURIN; GENE FREQUENCY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RNA; TRINUCLEOTIDE REPEATS;

EID: 77954240422     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2010.482449     Document Type: Article

References (25)

1. Abecasis, G. R., Cookson, W. O. (2000). GOLD-graphical overview of linkage disequilibrium. Bioinformatics, 16(2):182-183.
2. Agbas, A., Zaidi, A., Michaelis, E. K. (2005). Decreased activity and increased aggregation of brain calcineurin during aging. Brain Research, 1059(1):59-71.
3. Biala, G., Betancur, C., Mansuy, I. M., Giros, B. (2005). The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. European Journal of Neuroscience, 21(11):3,089-3,096.
4. Brion, J. P., Couck, A. M., Conreur, J. L. (1995). Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease. Neurodegeneration, 4(1):13-21.
5. Celsi, F., et al. (2007). Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiology of Disease, 26(2):342-352.
6. Gerber, D. J., et al. (2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proceedings of the National Academy of Sciences of the United States of America, 100(15):8,993-8,998.
7. Gerdjikov, T. V., Beninger, R. J. (2005). Differential effects of calcineurin inhibition and protein kinase A activation on nucleus accumbens amphetamine-produced conditioned place preference in rats. European Journal of Neuroscience, 22(3):697-705.
8. Gong, C. X., Liu, F., Grundke-Iqbal, I., Iqbal, K. (2006). Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target. Journal of Biomedical and Biotechnology, 2006(3):31,825.
9. Guerini, D., Klee, C. B. (1989). Cloning of human calcineurin A: evidence for two isozymes and identification of a polyproline structural domain. Proceedings of the National Academy of Sciences of the United States of America, 86(23):9,183-9,187.
10. Johnson, C. et al. (2006). Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. American Journal of Medical Genetics Part B: Neuropsychiatry Genetics, 141B(8):844-853.
11. Kincaid, R. L., et al. (1990). Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. Journal of Biological Chemistry, 265(19):11,312-11,319.
12. Klee, C. B., Crouch, T. H., Krinks, M. H. (1979). Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proceedings of the National Academy of Sciences of the United States of America, 76(12):6,270-6,273.
13. Lian, Q., Ladner, C. J., Magnuson, D., Lee, J. M. (2001). Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex. Experimental Neurology, 167(1):158-165.
14. Liu, F., Grundke-Iqbal, I., Iqbal, K., Oda, Y., Tomizawa, K., Gong, C. X. (2005a). Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. Journal of Biological Chemistry, 280(45):37,755-37,762.
15. Liu, Q. R., et al. (2005b). Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples. Proceedings of the National Academy of Sciences of the United States of America, 102(33):11,864-11,869.
16. Liu, Q. R., Lu, L., Zhu, X. G., Gong, J. P., Shaham, Y., Uhl, G. R. (2006). Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Research, 1067(1):1-12.
17. Malleret, G., et al. (2001). Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell, 104(5):675-686.
18. Mansuy, I. M., Mayford, M., Jacob, B., Kandel, E. R., Bach, M. E. (1998). Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell, 92(1):39-49.
19. Norris, C. M., et al. (2005). Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. Journal of Neuroscience, 25(18): 4,649-4,658.
20. Reuter, A., Mi, J., Sehrsam, I., Ludolph, A. C., Volkel, H. (2001). A novel calcineurin splice variant that modifies calcineurin activity. European Journal of Biochemistry, 268(22):5,955-5,960.
21. Stephens, M., Donnelly, P. (2003). A comparison of Bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics, 73(5):1,162-1,169.
22. Stephens, M., Smith, N. J., Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics, 68(4):978-989.
23. Uhl, G. R., Liu, Q. R., Walther, D., Hess, J., Naiman, D. (2001). Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. American Journal of Human Genetics, 69(6):1,290-1,300.
24. Winder, D. G., Mansuy, I. M., Osman, M., Moallem, T. M., Kandel, E. R. (1998). Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell, 92(1):25-37.
25. Yakel, J. L. (1997). Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends in Pharmacological Sciences, 18(4):124-34.